People with CF in Poland can be treated with CFTR modulators only at those centres where the “Treatment of patients with cystic fibrosis” drug program is implemented, and this covers the therapies with ivacaftor, ivacaftor with tezacaftor, ivacaftor with lumacaftor or ivacaftor with lumacaftor and elexacaftor. Here, CFTR is linked to cystic fibrosis.